一个更新的结构的oxybutynin化
Jieye Lin1, Guanhong Bu1, Johan Unge2
1Department of Biological Chemistry, University of California, Los Angeles, 615 Charles E. Young Drive South, Los Angeles, California 90095, United States.
bioRxiv : the preprint server for biology
|June 19, 2024
概括
研究人员使用微晶电子衍射 (MicroED) 揭示了oxybutynin化的3D晶体结构. 这一突破解决了与先前分析的不一致性,并有助于理解M3肌酸受体相互作用的药物开发.
科学领域:
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
- 晶体学 晶体学是指结晶学.
背景情况:
- 氧化丁氨酸化物是膀过活的肌肉抗剂,50年来没有明确的晶体结构.
- 以前的粉末X射线衍射 (PXRD) 研究由于样本和技术限制,提供了有限的见解.
研究的目的:
- 为了确定oxybutynin化的3D晶体结构.
- 为了研究 (R) -oxybutynin与M3肌肉蛋白受体 (M3R) 的结合机制.
- 为M3R对手提出一个普遍的构造.
主要方法:
- 微晶电子衍射 (MicroED) 被用来解决3D结构.
- 分子对接被用来研究 oxybutynin 和 M3R.之间的相互作用.
- 与现有的PXRD数据进行了比较.
主要成果:
- 顺利阐明了oxybutynin化的3D晶体结构.
- 发现了新结构与以前的PXRD分析之间的不一致性.
- 通过分子对接,M3R口袋中的关键结合相互作用和结构变化被揭示出来.
结论:
- 微ED是一种强大的技术,用于确定制药晶体结构和理解药物受体相互作用.
- 这项研究为氧丁宁-M3R结合提供了一个精细的模型,这对于设计新的M3R抗剂非常有价值.
- 提出了M3R抗剂的潜在通用构造,有助于未来的药物开发.
相关概念视频
Antihypertensive Drugs: Thiazide-Class Diuretics
598
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
598
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.2K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.9K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.9K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
129
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
129
Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Renal Drug Excretion: Tubular Secretion
174
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
174


